Examination Report |
1 | TM-1 | 07 Sep 2011 |
10 | Journal Copy | 16 Jul 2018 |
11 | Certificate | 16 Jul 2018 |
12 | TM-R(RENEWAL OF TRADE MARK) | 08 Sep 2021 |
13 | Note Sheet | 17 Feb 2022 |
14 | Renewal Certificate | 21 Feb 2022 |
2 | Additional Representation Sheet | 07 Sep 2011 |
3 | TM-5 | 19 Feb 2013 |
4 | Forwarding Letter for TM-5 | 07 May 2013 |
5 | TM-6 | 02 Jul 2013 |
6 | Forwarding Letter for TM-6 | 12 Sep 2013 |
7 | Hearing Notice | 20 Mar 2018 |
8 | Order | 08 Jun 2018 |
9 | Correspondence | 15 Jun 2018 |
1 | General Order | 4687728 | 07 Apr 2017 | |
2 | General Order | 5035109 | 14 Aug 2017 | |
3 | Generate Report | 6071581 | 16 Mar 2018 | |
4 | Decission Forwarding Letter | 6466722 | 05 Jun 2018 | |
5 | O3 NOTICE | 11644926 | 5226269 | 14 Jun 2021 |
6 | RENEWAL NOTICE | 13056074 | 21 Feb 2022 |
Trademark was applied on 07 September 2011 with IP India.
Proprietor of Glimipro is ANGLOFRENCH DRUGS AND INDUSTRIES.
Class(es) in which the trademark was applied to is 5.
Status of Glimipro is Registered.
Application number alloted to the trademark is 2201558.
Trademark has been filed in the following category:
WORD